Clinical Trials Directory

Trials / Completed

CompletedNCT02266901

Transluminal or Percutaneous Endoscopic Drainage and Debridement of Abcesses After Bariatric Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
9 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Patients presenting intra-abdominal abcesses following bariatric surgery complicated by fistulae are classically treated by external drainage and endoprosthesis or surgical redo. Morbidity and mortality being increased in case of necrotic collections, an endoscopic debridement treatment might be proposed in certain cases. This present study aim to review the evolution of the patients treated by this method from 2007 to 2011 in the investigators institution.

Detailed description

This retrospective study in an academic tertiary center will review the files of patients who underwent endoscopic drainage and debridement of abdominal abscesses secondary to bariatric surgery leaks . The decision for endoscopic treatment was made by the medico-surgical team in charge of this type of surgery, who had to weigh the high risk of mortality in case of re-intervention, along with endoscopic access to abscesses via the transluminal or percutaneous route based on abdominal imaging. Data collection will lead to the evaluation of the technical success rate, the clinical success and potential complications.

Conditions

Interventions

TypeNameDescription
PROCEDUREendoscopic drainageEndoscopic percutaneous access was obtained through surgical drains or after ultrasound-guided percutaneous drainage with a thin scope , and transluminal procedures with large scopes through the leak hole. All the procedures were performed under general anesthesia and carbon dioxide insufflation. Debridement was done by pus aspiration and irrigation.

Timeline

Start date
2007-10-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-10-17
Last updated
2014-10-17

Source: ClinicalTrials.gov record NCT02266901. Inclusion in this directory is not an endorsement.